Synthesis and evaluation of lysine derived sulfamides as histone deacetylase inhibitors
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (7) , 1866-1870
- https://doi.org/10.1016/j.bmcl.2009.02.075
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Isoform-selective histone deacetylase inhibitorsChemical Society Reviews, 2008
- Histone Deacetylase Inhibitors: From Bench to ClinicJournal of Medicinal Chemistry, 2008
- Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer CellsCurrent Pharmaceutical Biotechnology, 2007
- VorinostatNature Reviews Drug Discovery, 2007
- Chromatin Remodeling, Cancer and ChemotherapyCurrent Medicinal Chemistry, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- Histone Deacetylase Inhibitors: Latest Developments, Trends and ProspectsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- Histone deacetylases (HDACs): characterization of the classical HDAC familyBiochemical Journal, 2003
- Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.Proceedings of the National Academy of Sciences, 1996